Literature DB >> 22618958

Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009.

Peter Aka1, Esther Kawira, Nestory Masalu, Benjamin Emmanuel, Glen Brubaker, Josiah Magatti, Sam M Mbulaiteye.   

Abstract

INTRODUCTION: Burkitt lymphoma (BL) is endemic in parts of Tanzania, but there is scant country or region level data about burden and trends of BL in Tanzania over the past three decades. Here, we update baseline epidemiology of BL in northern Tanzania using recent data. PROCEDURE: Data for childhood BL diagnosed at six hospitals in Mara and Mwanza regions in northern Tanzania during 2000-2009 were compiled. Age, sex, and regional patterns were analyzed. Crude incidence rates of BL were calculated by sex, anatomic site, geographical region, and calendar year.
RESULTS: Among 944 cases, 549 (58%) were male (male/female case ratio 1.4:1). Among those with known anatomic site (92%), facial only tumors represented a large proportion of tumors in boys than girls (50% vs. 36%, P < 0.002). Tumors occurred at a younger mean age in boys than girls (6.8 years vs. 7.6 years, P < 0.01). Crude BL incidence was 4.2 per 100,000, but varied by region (3.0 in Mwanza vs. 6.8 in Mara, P = 0.01), by district (1.4-22), by gender (5.0 in boys vs. 4.0 in girls), and by age group (2.0 in 0-4, 7.8 in 5-9, and 3.1 in 10-15 years). BL incidence peaked in 2001 and decreased gradually thereafter.
CONCLUSIONS: Our results indicate that male sex, young age, and geographical characteristics are risk factors for BL in Tanzania. BL incidence declined with calendar year, but the significance of this finding is uncertain. Well-designed epidemiological studies of BL in Tanzania may shed light on environmental characteristics underlying these patterns.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22618958      PMCID: PMC3427713          DOI: 10.1002/pbc.24194

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  32 in total

1.  Sick individuals and sick populations. 1985.

Authors:  G Rose
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

2.  Higher risk behaviour and rates of sexually transmitted diseases in Mwanza compared to Uganda may help explain HIV prevention trial outcomes.

Authors:  Kate K Orroth; Eline L Korenromp; Richard G White; Awene Gavyole; Ron H Gray; Lawrence Muhangi; Nelson K Sewankambo; Maria Quigley; Maria J Wawer; James A Whitworth; Heiner Grosskurth; J Dik Habbema; Richard J Hayes
Journal:  AIDS       Date:  2003-12-05       Impact factor: 4.177

3.  Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study.

Authors:  G de-Thé; A Geser; N E Day; P M Tukei; E H Williams; D P Beri; P G Smith; A G Dean; G W Bronkamm; P Feorino; W Henle
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

Review 4.  Part I: Cancer in Indigenous Africans--burden, distribution, and trends.

Authors:  D Max Parkin; Freddy Sitas; Mike Chirenje; Lara Stein; Raymond Abratt; Henry Wabinga
Journal:  Lancet Oncol       Date:  2008-07       Impact factor: 41.316

5.  Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited.

Authors:  Martin D Ogwang; Kishor Bhatia; Robert J Biggar; Sam M Mbulaiteye
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

6.  Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.

Authors:  Lucy M Carpenter; Robert Newton; Delphine Casabonne; John Ziegler; Sam Mbulaiteye; Edward Mbidde; Henry Wabinga; Harold Jaffe; Valerie Beral
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

7.  Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma.

Authors:  A Geser; G de Thé; G Lenoir; N E Day; E H Williams
Journal:  Int J Cancer       Date:  1982-04-15       Impact factor: 7.396

8.  Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005.

Authors:  Sam M Mbulaiteye; Robert J Biggar; Kishor Bhatia; Martha S Linet; Susan S Devesa
Journal:  Pediatr Blood Cancer       Date:  2009-09       Impact factor: 3.167

9.  Genetics of susceptibility to malaria related phenotypes.

Authors:  Danielle Carpenter; Ingegerd Rooth; Anna Färnert; Hind Abushama; Rupert J Quinnell; Marie-Anne Shaw
Journal:  Infect Genet Evol       Date:  2008-10-31       Impact factor: 3.342

10.  Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study.

Authors:  Nora Mutalima; Elizabeth Molyneux; Harold Jaffe; Steve Kamiza; Eric Borgstein; Nyengo Mkandawire; George Liomba; Mkume Batumba; Dimitrios Lagos; Fiona Gratrix; Chris Boshoff; Delphine Casabonne; Lucy M Carpenter; Robert Newton
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  14 in total

Review 1.  Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.

Authors:  Chris A Rees; Elizabeth M Keating; Heather Lukolyo; Heather E Danysh; Michael E Scheurer; Parth S Mehta; Joseph Lubega; Jeremy S Slone
Journal:  Pediatr Blood Cancer       Date:  2016-04-15       Impact factor: 3.167

2.  A population-based study of the prevalence and risk factors of low-grade Plasmodium falciparum malaria infection in children aged 0-15 years old in northern Tanzania.

Authors:  S Peprah; H Dhudha; H Ally; N Masalu; E Kawira; C N Chao; I O Genga; M Mumia; P A Were; T Kinyera; I Otim; I D Legason; R J Biggar; K Bhatia; J J Goedert; R M Pfeiffer; S M Mbulaiteye
Journal:  Trop Med Int Health       Date:  2019-04-01       Impact factor: 2.622

3.  Incidence of Endemic Burkitt Lymphoma in Three Regions of Mozambique.

Authors:  Cristina O'Callaghan-Gordo; Delphine Casabonne; Carla Carrilho; Josefo Ferro; Cesaltina Lorenzoni; Clesio Zaqueu; Augusto Nhabomba; Ruth Aguilar; Quique Bassat; Sílvia de Sanjosé; Carlota Dobaño; Manolis Kogevinas
Journal:  Am J Trop Med Hyg       Date:  2016-10-31       Impact factor: 2.345

Review 4.  Paediatric non-Hodgkin lymphoma in low and middle income countries.

Authors:  Thomas G Gross; Andrea Biondi
Journal:  Br J Haematol       Date:  2016-04-20       Impact factor: 6.998

Review 5.  Building capacity for sustainable research programmes for cancer in Africa.

Authors:  Isaac Adewole; Damali N Martin; Makeda J Williams; Clement Adebamowo; Kishor Bhatia; Christine Berling; Corey Casper; Karima Elshamy; Ahmed Elzawawy; Rita T Lawlor; Rosa Legood; Sam M Mbulaiteye; Folakemi T Odedina; Olufunmilayo I Olopade; Christopher O Olopade; Donald M Parkin; Timothy R Rebbeck; Hana Ross; Luiz A Santini; Julie Torode; Edward L Trimble; Christopher P Wild; Annie M Young; David J Kerr
Journal:  Nat Rev Clin Oncol       Date:  2014-03-11       Impact factor: 66.675

Review 6.  Malaria and Cancer: a critical review on the established associations and new perspectives.

Authors:  Toby Ellis; Elvis Eze; Bahijja Tolulope Raimi-Abraham
Journal:  Infect Agent Cancer       Date:  2021-05-13       Impact factor: 2.965

7.  Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.

Authors:  Rogatus Kabyemera; Nestory Masalu; Peter Rambau; Erasmus Kamugisha; Benson Kidenya; Anita De Rossi; Maria Raffaella Petrara; Damas Mwizamuholya
Journal:  BMC Pediatr       Date:  2013-01-07       Impact factor: 2.125

8.  The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells.

Authors:  Chuntuan Li; Pengliang Xin; Huifang Xiao; Yan Zheng; Yuanling Huang; Xiongpeng Zhu
Journal:  Cancer Cell Int       Date:  2015-06-24       Impact factor: 5.722

9.  Burkitt lymphoma research in East Africa: highlights from the 9(th) African organization for research and training in cancer conference held in Durban, South Africa in 2013.

Authors:  Kenneth O Simbiri; Joshua Biddle; Tobias Kinyera; Pamela Akinyi Were; Constance Tenge; Esther Kawira; Nestory Masalu; Peter Odada Sumba; Janet Lawler-Heavner; Cristina D Stefan; Franco M Buonaguro; Detra Robinson; Robert Newton; Joe Harford; Kishor Bhatia; Sam M Mbulaiteye
Journal:  Infect Agent Cancer       Date:  2014-09-11       Impact factor: 2.965

10.  Risk factors for Burkitt lymphoma in East African children and minors: A case-control study in malaria-endemic regions in Uganda, Tanzania and Kenya.

Authors:  Sally Peprah; Martin D Ogwang; Patrick Kerchan; Steven J Reynolds; Constance N Tenge; Pamela A Were; Robert T Kuremu; Walter N Wekesa; Peter O Sumba; Nestory Masalu; Esther Kawira; Josiah Magatti; Tobias Kinyera; Isaac Otim; Ismail D Legason; Hadijah Nabalende; Herry Dhudha; Hillary Ally; Isaiah O Genga; Mediatrix Mumia; Leona W Ayers; Ruth M Pfeiffer; Robert J Biggar; Kishor Bhatia; James J Goedert; Sam M Mbulaiteye
Journal:  Int J Cancer       Date:  2019-05-20       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.